Introduction. There is not much evidence regarding clinical behavior of bladder cancer in younger patients. We evaluated clinical characteristics, tumor recurrence and progression in patients younger than 40 years old with urothelial bladder carcinoma. Methods. We retrospectively reviewed the medical records of 31 patients less than 40 years old who were firstly managed with bladder urothelial carcinoma in our department. Data were analysed with the Chi-square test. Results. Mean age was 31.7 years. Mean followup was 38.52 months (11–72 months). Nineteen (61%) patients were diagnosed with GII and 2 (6%) patients with GIII disease. Five (16%) patients presented with T1 disease. Three (9%) patients with invasive disease underwent cystectomy ...
Records of fifteen patients less than 40 years old with carcinoma of the bladder are reviewed. Fourt...
Urothelial bladder carcinoma is a rare condition in young patients. Clinicians have less inclination...
Objectives: to evaluate the clinicopathological features, recurrence and survival in patients up to ...
Background. There is not enough evidence about clinical behavior of bladder cancer in younger patien...
BackgroundThe clinical behavior and prognosis of bladder cancer in young patients is not well define...
The clinical behavior and prognosis of bladder cancer in young patients is not well defined. The aim...
AbstractBladder urothelial carcinoma is rare in young adults and occurs more commonly in older indiv...
Introduction: The aim of the study is to reveal pathologic characteristics and clinical behaviour of...
We aimed to evaluate the potential effect of age on the natural behavior of bladder cancer and to co...
Introduction: Urothelial carcinoma of urinary blad-der is rare before age of 40 years. The issue reg...
Tumors of the bladder, particularly urothelial carcinoma (UC) are very rare malignant diseases in yo...
International audienceUrothelial bladder cancer (UBC) is rare in young patients and as a result litt...
Objective: To report 2 pediatric urology referral centers' experience on transitional cell carcinoma...
Bladder cancer is the 2nd urological cancer, most known in people over 50 years old. We are witnessi...
AbstractWe aimed to evaluate the potential effect of age on the natural behavior of bladder cancer a...
Records of fifteen patients less than 40 years old with carcinoma of the bladder are reviewed. Fourt...
Urothelial bladder carcinoma is a rare condition in young patients. Clinicians have less inclination...
Objectives: to evaluate the clinicopathological features, recurrence and survival in patients up to ...
Background. There is not enough evidence about clinical behavior of bladder cancer in younger patien...
BackgroundThe clinical behavior and prognosis of bladder cancer in young patients is not well define...
The clinical behavior and prognosis of bladder cancer in young patients is not well defined. The aim...
AbstractBladder urothelial carcinoma is rare in young adults and occurs more commonly in older indiv...
Introduction: The aim of the study is to reveal pathologic characteristics and clinical behaviour of...
We aimed to evaluate the potential effect of age on the natural behavior of bladder cancer and to co...
Introduction: Urothelial carcinoma of urinary blad-der is rare before age of 40 years. The issue reg...
Tumors of the bladder, particularly urothelial carcinoma (UC) are very rare malignant diseases in yo...
International audienceUrothelial bladder cancer (UBC) is rare in young patients and as a result litt...
Objective: To report 2 pediatric urology referral centers' experience on transitional cell carcinoma...
Bladder cancer is the 2nd urological cancer, most known in people over 50 years old. We are witnessi...
AbstractWe aimed to evaluate the potential effect of age on the natural behavior of bladder cancer a...
Records of fifteen patients less than 40 years old with carcinoma of the bladder are reviewed. Fourt...
Urothelial bladder carcinoma is a rare condition in young patients. Clinicians have less inclination...
Objectives: to evaluate the clinicopathological features, recurrence and survival in patients up to ...